▶ 調査レポート

植物性ワクチンのグローバル市場インサイト・予測(~2027年)

• 英文タイトル:Global Plant-based Vaccines Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。植物性ワクチンのグローバル市場インサイト・予測(~2027年) / Global Plant-based Vaccines Market Insights and Forecast to 2027 / QY2112C03660資料のイメージです。• レポートコード:QY2112C03660
• 出版社/出版日:QYResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療装置
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,102,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は植物性ワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。植物性ワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(細菌ワクチン、ウイルスワクチン)、用途別市場規模(抗感染症、抗癌、抗自己免疫疾患)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・植物性ワクチンの世界市場概要
・メーカー別の競争状況、市場シェア
・植物性ワクチンの種類別市場規模:細菌ワクチン、ウイルスワクチン
・植物性ワクチンの用途別市場規模:抗感染症、抗癌、抗自己免疫疾患
・北米の植物性ワクチン市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの植物性ワクチン市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの植物性ワクチン市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の植物性ワクチン市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの植物性ワクチン市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Creative Biolabs、Medicago、iBio、ICON、EEA Consulting Engineers、Protalix、Kentucky BioProcessing
・植物性ワクチンのバリューチェーン・販売チャネル分析
・植物性ワクチンの世界市場動向

Market Analysis and Insights: Global Plant-based Vaccines Market
The global Plant-based Vaccines market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Plant-based Vaccines Scope and Segment
Plant-based Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plant-based Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Bacterial Vaccine
Viral Vaccine

Segment by Application
Anti-Infective
Anti-Cancer
Anti-Autoimmune Disease

By Company
Creative Biolabs
Medicago
iBio
ICON
EEA Consulting Engineers
Protalix
Kentucky BioProcessing

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Plant-based Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Plant-based Vaccines Market Size Growth Rate by Type
1.2.2 Bacterial Vaccine
1.2.3 Viral Vaccine
1.3 Market by Application
1.3.1 Global Plant-based Vaccines Market Size Growth Rate by Application
1.3.2 Anti-Infective
1.3.3 Anti-Cancer
1.3.4 Anti-Autoimmune Disease
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Plant-based Vaccines Sales Estimates and Forecasts 2016-2027
2.2 Global Plant-based Vaccines Revenue Estimates and Forecasts 2016-2027
2.3 Global Plant-based Vaccines Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Plant-based Vaccines Regions by Sales
2.4.1 Global Top Plant-based Vaccines Regions by Sales (2016-2021)
2.4.2 Global Top Plant-based Vaccines Regions by Sales (2022-2027)
2.5 Global Top Plant-based Vaccines Regions by Revenue
2.5.1 Global Top Plant-based Vaccines Regions by Revenue (2016-2021)
2.5.2 Global Top Plant-based Vaccines Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Plant-based Vaccines Sales by Manufacturers
3.1.1 Global Top Plant-based Vaccines Manufacturers by Sales (2016-2021)
3.1.2 Global Top Plant-based Vaccines Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Plant-based Vaccines Sales in 2020
3.2 Global Plant-based Vaccines Revenue by Manufacturers
3.2.1 Global Top Plant-based Vaccines Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Plant-based Vaccines Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Plant-based Vaccines Revenue in 2020
3.3 Global Plant-based Vaccines Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Plant-based Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Plant-based Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Plant-based Vaccines Sales by Type
4.1.1 Global Plant-based Vaccines Historical Sales by Type (2016-2021)
4.1.2 Global Plant-based Vaccines Forecasted Sales by Type (2022-2027)
4.1.3 Global Plant-based Vaccines Sales Market Share by Type (2016-2027)
4.2 Global Plant-based Vaccines Revenue by Type
4.2.1 Global Plant-based Vaccines Historical Revenue by Type (2016-2021)
4.2.2 Global Plant-based Vaccines Forecasted Revenue by Type (2022-2027)
4.2.3 Global Plant-based Vaccines Revenue Market Share by Type (2016-2027)
4.3 Global Plant-based Vaccines Price by Type
4.3.1 Global Plant-based Vaccines Price by Type (2016-2021)
4.3.2 Global Plant-based Vaccines Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Plant-based Vaccines Sales by Application
5.1.1 Global Plant-based Vaccines Historical Sales by Application (2016-2021)
5.1.2 Global Plant-based Vaccines Forecasted Sales by Application (2022-2027)
5.1.3 Global Plant-based Vaccines Sales Market Share by Application (2016-2027)
5.2 Global Plant-based Vaccines Revenue by Application
5.2.1 Global Plant-based Vaccines Historical Revenue by Application (2016-2021)
5.2.2 Global Plant-based Vaccines Forecasted Revenue by Application (2022-2027)
5.2.3 Global Plant-based Vaccines Revenue Market Share by Application (2016-2027)
5.3 Global Plant-based Vaccines Price by Application
5.3.1 Global Plant-based Vaccines Price by Application (2016-2021)
5.3.2 Global Plant-based Vaccines Price Forecast by Application (2022-2027)

6 North America
6.1 North America Plant-based Vaccines Market Size by Type
6.1.1 North America Plant-based Vaccines Sales by Type (2016-2027)
6.1.2 North America Plant-based Vaccines Revenue by Type (2016-2027)
6.2 North America Plant-based Vaccines Market Size by Application
6.2.1 North America Plant-based Vaccines Sales by Application (2016-2027)
6.2.2 North America Plant-based Vaccines Revenue by Application (2016-2027)
6.3 North America Plant-based Vaccines Market Size by Country
6.3.1 North America Plant-based Vaccines Sales by Country (2016-2027)
6.3.2 North America Plant-based Vaccines Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Plant-based Vaccines Market Size by Type
7.1.1 Europe Plant-based Vaccines Sales by Type (2016-2027)
7.1.2 Europe Plant-based Vaccines Revenue by Type (2016-2027)
7.2 Europe Plant-based Vaccines Market Size by Application
7.2.1 Europe Plant-based Vaccines Sales by Application (2016-2027)
7.2.2 Europe Plant-based Vaccines Revenue by Application (2016-2027)
7.3 Europe Plant-based Vaccines Market Size by Country
7.3.1 Europe Plant-based Vaccines Sales by Country (2016-2027)
7.3.2 Europe Plant-based Vaccines Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Plant-based Vaccines Market Size by Type
8.1.1 Asia Pacific Plant-based Vaccines Sales by Type (2016-2027)
8.1.2 Asia Pacific Plant-based Vaccines Revenue by Type (2016-2027)
8.2 Asia Pacific Plant-based Vaccines Market Size by Application
8.2.1 Asia Pacific Plant-based Vaccines Sales by Application (2016-2027)
8.2.2 Asia Pacific Plant-based Vaccines Revenue by Application (2016-2027)
8.3 Asia Pacific Plant-based Vaccines Market Size by Region
8.3.1 Asia Pacific Plant-based Vaccines Sales by Region (2016-2027)
8.3.2 Asia Pacific Plant-based Vaccines Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Plant-based Vaccines Market Size by Type
9.1.1 Latin America Plant-based Vaccines Sales by Type (2016-2027)
9.1.2 Latin America Plant-based Vaccines Revenue by Type (2016-2027)
9.2 Latin America Plant-based Vaccines Market Size by Application
9.2.1 Latin America Plant-based Vaccines Sales by Application (2016-2027)
9.2.2 Latin America Plant-based Vaccines Revenue by Application (2016-2027)
9.3 Latin America Plant-based Vaccines Market Size by Country
9.3.1 Latin America Plant-based Vaccines Sales by Country (2016-2027)
9.3.2 Latin America Plant-based Vaccines Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Plant-based Vaccines Market Size by Type
10.1.1 Middle East and Africa Plant-based Vaccines Sales by Type (2016-2027)
10.1.2 Middle East and Africa Plant-based Vaccines Revenue by Type (2016-2027)
10.2 Middle East and Africa Plant-based Vaccines Market Size by Application
10.2.1 Middle East and Africa Plant-based Vaccines Sales by Application (2016-2027)
10.2.2 Middle East and Africa Plant-based Vaccines Revenue by Application (2016-2027)
10.3 Middle East and Africa Plant-based Vaccines Market Size by Country
10.3.1 Middle East and Africa Plant-based Vaccines Sales by Country (2016-2027)
10.3.2 Middle East and Africa Plant-based Vaccines Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Corporation Information
11.1.2 Creative Biolabs Overview
11.1.3 Creative Biolabs Plant-based Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Creative Biolabs Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Creative Biolabs Recent Developments
11.2 Medicago
11.2.1 Medicago Corporation Information
11.2.2 Medicago Overview
11.2.3 Medicago Plant-based Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Medicago Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medicago Recent Developments
11.3 iBio
11.3.1 iBio Corporation Information
11.3.2 iBio Overview
11.3.3 iBio Plant-based Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 iBio Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 iBio Recent Developments
11.4 ICON
11.4.1 ICON Corporation Information
11.4.2 ICON Overview
11.4.3 ICON Plant-based Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 ICON Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 ICON Recent Developments
11.5 EEA Consulting Engineers
11.5.1 EEA Consulting Engineers Corporation Information
11.5.2 EEA Consulting Engineers Overview
11.5.3 EEA Consulting Engineers Plant-based Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 EEA Consulting Engineers Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 EEA Consulting Engineers Recent Developments
11.6 Protalix
11.6.1 Protalix Corporation Information
11.6.2 Protalix Overview
11.6.3 Protalix Plant-based Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Protalix Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Protalix Recent Developments
11.7 Kentucky BioProcessing
11.7.1 Kentucky BioProcessing Corporation Information
11.7.2 Kentucky BioProcessing Overview
11.7.3 Kentucky BioProcessing Plant-based Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Kentucky BioProcessing Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kentucky BioProcessing Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Plant-based Vaccines Value Chain Analysis
12.2 Plant-based Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plant-based Vaccines Production Mode & Process
12.4 Plant-based Vaccines Sales and Marketing
12.4.1 Plant-based Vaccines Sales Channels
12.4.2 Plant-based Vaccines Distributors
12.5 Plant-based Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Plant-based Vaccines Industry Trends
13.2 Plant-based Vaccines Market Drivers
13.3 Plant-based Vaccines Market Challenges
13.4 Plant-based Vaccines Market Restraints

14 Key Findings in The Global Plant-based Vaccines Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Plant-based Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Bacterial Vaccine
Table 3. Major Manufacturers of Viral Vaccine
Table 4. Global Plant-based Vaccines Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Plant-based Vaccines Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Plant-based Vaccines Sales by Region (2016-2021) & (K Units)
Table 7. Global Plant-based Vaccines Sales Market Share by Region (2016-2021)
Table 8. Global Plant-based Vaccines Sales by Region (2022-2027) & (K Units)
Table 9. Global Plant-based Vaccines Sales Market Share by Region (2022-2027)
Table 10. Global Plant-based Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Plant-based Vaccines Revenue Market Share by Region (2016-2021)
Table 12. Global Plant-based Vaccines Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Plant-based Vaccines Revenue Market Share by Region (2022-2027)
Table 14. Global Plant-based Vaccines Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Plant-based Vaccines Sales Share by Manufacturers (2016-2021)
Table 16. Global Plant-based Vaccines Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Plant-based Vaccines Revenue Share by Manufacturers (2016-2021)
Table 18. Plant-based Vaccines Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Plant-based Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Plant-based Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant-based Vaccines as of 2020)
Table 21. Plant-based Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Plant-based Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Plant-based Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Plant-based Vaccines Sales by Type (2016-2021) & (K Units)
Table 26. Global Plant-based Vaccines Sales by Type (2022-2027) & (K Units)
Table 27. Global Plant-based Vaccines Sales Share by Type (2016-2021)
Table 28. Global Plant-based Vaccines Sales Share by Type (2022-2027)
Table 29. Global Plant-based Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Plant-based Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Plant-based Vaccines Revenue Share by Type (2016-2021)
Table 32. Global Plant-based Vaccines Revenue Share by Type (2022-2027)
Table 33. Plant-based Vaccines Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Plant-based Vaccines Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Plant-based Vaccines Sales by Application (2016-2021) & (K Units)
Table 36. Global Plant-based Vaccines Sales by Application (2022-2027) & (K Units)
Table 37. Global Plant-based Vaccines Sales Share by Application (2016-2021)
Table 38. Global Plant-based Vaccines Sales Share by Application (2022-2027)
Table 39. Global Plant-based Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Plant-based Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Plant-based Vaccines Revenue Share by Application (2016-2021)
Table 42. Global Plant-based Vaccines Revenue Share by Application (2022-2027)
Table 43. Plant-based Vaccines Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Plant-based Vaccines Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Plant-based Vaccines Sales by Type (2016-2021) & (K Units)
Table 46. North America Plant-based Vaccines Sales by Type (2022-2027) & (K Units)
Table 47. North America Plant-based Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Plant-based Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Plant-based Vaccines Sales by Application (2016-2021) & (K Units)
Table 50. North America Plant-based Vaccines Sales by Application (2022-2027) & (K Units)
Table 51. North America Plant-based Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Plant-based Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Plant-based Vaccines Sales by Country (2016-2021) & (K Units)
Table 54. North America Plant-based Vaccines Sales by Country (2022-2027) & (K Units)
Table 55. North America Plant-based Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Plant-based Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Plant-based Vaccines Sales by Type (2016-2021) & (K Units)
Table 58. Europe Plant-based Vaccines Sales by Type (2022-2027) & (K Units)
Table 59. Europe Plant-based Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Plant-based Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Plant-based Vaccines Sales by Application (2016-2021) & (K Units)
Table 62. Europe Plant-based Vaccines Sales by Application (2022-2027) & (K Units)
Table 63. Europe Plant-based Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Plant-based Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Plant-based Vaccines Sales by Country (2016-2021) & (K Units)
Table 66. Europe Plant-based Vaccines Sales by Country (2022-2027) & (K Units)
Table 67. Europe Plant-based Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Plant-based Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Plant-based Vaccines Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Plant-based Vaccines Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Plant-based Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Plant-based Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Plant-based Vaccines Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Plant-based Vaccines Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Plant-based Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Plant-based Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Plant-based Vaccines Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Plant-based Vaccines Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Plant-based Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Plant-based Vaccines Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Plant-based Vaccines Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Plant-based Vaccines Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Plant-based Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Plant-based Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Plant-based Vaccines Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Plant-based Vaccines Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Plant-based Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Plant-based Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Plant-based Vaccines Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Plant-based Vaccines Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Plant-based Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Plant-based Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Plant-based Vaccines Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Plant-based Vaccines Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Plant-based Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Plant-based Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Plant-based Vaccines Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Plant-based Vaccines Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Plant-based Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Plant-based Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Plant-based Vaccines Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Plant-based Vaccines Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Plant-based Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Plant-based Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 105. Creative Biolabs Corporation Information
Table 106. Creative Biolabs Description and Major Businesses
Table 107. Creative Biolabs Plant-based Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Creative Biolabs Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Creative Biolabs Recent Developments
Table 110. Medicago Corporation Information
Table 111. Medicago Description and Major Businesses
Table 112. Medicago Plant-based Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Medicago Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Medicago Recent Developments
Table 115. iBio Corporation Information
Table 116. iBio Description and Major Businesses
Table 117. iBio Plant-based Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. iBio Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. iBio Recent Developments
Table 120. ICON Corporation Information
Table 121. ICON Description and Major Businesses
Table 122. ICON Plant-based Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. ICON Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. ICON Recent Developments
Table 125. EEA Consulting Engineers Corporation Information
Table 126. EEA Consulting Engineers Description and Major Businesses
Table 127. EEA Consulting Engineers Plant-based Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. EEA Consulting Engineers Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. EEA Consulting Engineers Recent Developments
Table 130. Protalix Corporation Information
Table 131. Protalix Description and Major Businesses
Table 132. Protalix Plant-based Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Protalix Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Protalix Recent Developments
Table 135. Kentucky BioProcessing Corporation Information
Table 136. Kentucky BioProcessing Description and Major Businesses
Table 137. Kentucky BioProcessing Plant-based Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Kentucky BioProcessing Plant-based Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Kentucky BioProcessing Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Plant-based Vaccines Distributors List
Table 143. Plant-based Vaccines Customers List
Table 144. Plant-based Vaccines Market Trends
Table 145. Plant-based Vaccines Market Drivers
Table 146. Plant-based Vaccines Market Challenges
Table 147. Plant-based Vaccines Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Plant-based Vaccines Product Picture
Figure 2. Global Plant-based Vaccines Market Share by Type in 2020 & 2027
Figure 3. Bacterial Vaccine Product Picture
Figure 4. Viral Vaccine Product Picture
Figure 5. Global Plant-based Vaccines Market Share by Application in 2020 & 2027
Figure 6. Anti-Infective
Figure 7. Anti-Cancer
Figure 8. Anti-Autoimmune Disease
Figure 9. Plant-based Vaccines Report Years Considered
Figure 10. Global Plant-based Vaccines Sales 2016-2027 (K Units)
Figure 11. Global Plant-based Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Plant-based Vaccines Revenue 2016-2027 (US$ Million)
Figure 13. Global Plant-based Vaccines Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Plant-based Vaccines Sales Market Share by Region (2016-2021)
Figure 15. Global Plant-based Vaccines Sales Market Share by Region (2022-2027)
Figure 16. North America Plant-based Vaccines Sales YoY (2016-2027) & (K Units)
Figure 17. North America Plant-based Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Plant-based Vaccines Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Plant-based Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Plant-based Vaccines Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Plant-based Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Plant-based Vaccines Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Plant-based Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Plant-based Vaccines Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Plant-based Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Plant-based Vaccines Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Plant-based Vaccines Revenue in 2020
Figure 28. Plant-based Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Plant-based Vaccines Sales Market Share by Type (2016-2027)
Figure 30. Global Plant-based Vaccines Revenue Market Share by Type (2016-2027)
Figure 31. Global Plant-based Vaccines Sales Market Share by Application (2016-2027)
Figure 32. Global Plant-based Vaccines Revenue Market Share by Application (2016-2027)
Figure 33. North America Plant-based Vaccines Sales Market Share by Type (2016-2027)
Figure 34. North America Plant-based Vaccines Revenue Market Share by Type (2016-2027)
Figure 35. North America Plant-based Vaccines Sales Market Share by Application (2016-2027)
Figure 36. North America Plant-based Vaccines Revenue Market Share by Application (2016-2027)
Figure 37. North America Plant-based Vaccines Sales Share by Country (2016-2027)
Figure 38. North America Plant-based Vaccines Revenue Share by Country (2016-2027)
Figure 39. United States Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Plant-based Vaccines Sales Market Share by Type (2016-2027)
Figure 42. Europe Plant-based Vaccines Revenue Market Share by Type (2016-2027)
Figure 43. Europe Plant-based Vaccines Sales Market Share by Application (2016-2027)
Figure 44. Europe Plant-based Vaccines Revenue Market Share by Application (2016-2027)
Figure 45. Europe Plant-based Vaccines Sales Share by Country (2016-2027)
Figure 46. Europe Plant-based Vaccines Revenue Share by Country (2016-2027)
Figure 47. Germany Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 48. France Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Plant-based Vaccines Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Plant-based Vaccines Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Plant-based Vaccines Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Plant-based Vaccines Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Plant-based Vaccines Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Plant-based Vaccines Revenue Share by Region (2016-2027)
Figure 58. China Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 61. India Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Plant-based Vaccines Sales Market Share by Type (2016-2027)
Figure 68. Latin America Plant-based Vaccines Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Plant-based Vaccines Sales Market Share by Application (2016-2027)
Figure 70. Latin America Plant-based Vaccines Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Plant-based Vaccines Sales Share by Country (2016-2027)
Figure 72. Latin America Plant-based Vaccines Revenue Share by Country (2016-2027)
Figure 73. Mexico Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Plant-based Vaccines Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Plant-based Vaccines Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Plant-based Vaccines Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Plant-based Vaccines Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Plant-based Vaccines Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Plant-based Vaccines Revenue Share by Country (2016-2027)
Figure 82. Turkey Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Plant-based Vaccines Revenue (2016-2027) & (US$ Million)
Figure 85. Plant-based Vaccines Value Chain
Figure 86. Plant-based Vaccines Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed